SFDA’s New Digital Health Regulatory Guidance (MDS-G27): What You Must Know
SFDA’s New Digital Health Regulatory Guidance (MDS-G27): What You Must Know riarcompany.2025@gmail.com January 14, 2026 Uncategorized The Saudi Food & Drug Authority (SFDA) has recently released MDS-G27, a new regulatory guidance for Digital Health Products, marking a significant shift in how digital health solutions are classified, assessed, and regulated in the Kingdom of Saudi Arabia. […]
SFDA Releases Version 3.0 of Verification & Abridged Pathways Guideline
SFDA Releases Version 3.0 of Verification & Abridged Pathways Guideline riarcompany.2025@gmail.com January 12, 2026 SFDA Regulatory Updates RIAR Consulting is pleased to share an important regulatory update from the Saudi Food & Drug Authority (SFDA) that will significantly impact pharmaceutical product registration and lifecycle management in Saudi Arabia. The SFDA has officially released Version 3.0 […]
